Saiseikai Nagasaki Hospital
Nagasaki, Japan
General hospital in Nagasaki
〒850-0003 Nagasaki, Katafuchi, 2 Chome−5−1 済生会長崎病院（済生会支部）
About Saiseikai Nagasaki Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Bayer
1
Gynecologic Oncology Trial & Investigation Consortium
1
Japanese Gynecologic Oncology Group
1
Clinical Trials at Saiseikai Nagasaki Hospital
During the past decade, Saiseikai Nagasaki Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Intraperitoneal Therapy For Ovarian Cancer With Carboplatin Trial
2010-05-01
2021-02-28
Completed
655
Study to Gather Information How Well Three Different Doses of BAY1817080 Given Twice Daily Over 12 Weeks Work in Comparison to an Inactive Pill (Placebo) and Elagolix in Women Suffering From Pain Related to a Condition Where the Tissue That Usually Grows Inside the Womb Grows Outside of the Womb
2021-01-29
2022-05-03
Completed
194
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Saiseikai Nagasaki Hospital"
#1 collaborator was "Japanese Gynecologic Oncology Group" with 1 trials as a collaborator and "Korean Gynecologic Oncology Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Saiseikai Nagasaki Hospital
According to Clinical.Site data, the most researched conditions in "Saiseikai Nagasaki Hospital" are
"Epithelial Ovarian Cancer" (2 trials), "Endometriosis" (1 trials), "Fallopian Tube Cancer" (1 trials) and "Primary Peritoneal Carcinoma" (1 trials). Many other conditions were trialed in "Saiseikai Nagasaki Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Saiseikai Nagasaki Hospital
Most popular intervention types in "Saiseikai Nagasaki Hospital" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "BAY1817080" (1 trials), "Elagolix" (1 trials), "Paclitaxel(intravenous) + Carboplatin(intraperitoneal)" (1 trials), "Paclitaxel(intravenous) + Carboplatin(intravenous)" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Saiseikai Nagasaki Hospital
The vast majority of trials in "Saiseikai Nagasaki Hospital" are
3 trials for "Female" genders.
Clinical Trials Status at Saiseikai Nagasaki Hospital
Currently, there are NaN active trials in "Saiseikai Nagasaki Hospital".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Saiseikai Nagasaki Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Saiseikai Nagasaki Hospital, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".